CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy
Completed
Conditions studied: Cervical Dystonia
In brief
This study is an observational trial which will measure the efficacy of onabotulinumtoxinA in treating Cervical Dystonia.
Key facts
- Study ID
- NCT00836017
- Run by
- Allergan
- People needed
- 1046
- Starts
- 2009-01-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2014-07-17
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with Cervical Dystonia
- Candidate for botulinum toxin type A therapy
- New to physician's practice, and/or new to botulinum toxin type A therapy, or has not been injected with botulinum toxin type A for at least 16 weeks as a participant in another clinical trial investigating botulinum toxin type A for cervical dystonia
- Able to follow study instructions and complete study activities
You may not qualify if…
- Patients undergoing elective surgery during the trial period
- Females who are pregnant, nursing, or planning a pregnancy
- History of poor cooperation or compliance with medical treatment or unreliability
- Any condition or situation in which, in the investigator's opinion, places the patient at significant risk, could confound the study data, or may interfere with the patient's participation in the study, including but not limited to unstable medical conditions
Where it is running
- Study site — Springfield, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.